Search Results for: cancer
Innovation AIMayo ClinicCancer
Mayo Clinic Researchers Invent Hypothesis-Driven AI for Cancer Research Breakthroughs
2024-03-14
IPO IPO
Chinese Biotechs Seeks IPO Growth on US Shores
2024-03-13
Partnerships Synthetic BiologyMerckStartup
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
R&D Environment
German Study Links PFAS Exposure to Adverse Lipid Profiles and Cardiovascular Risk
2024-03-13
Interviews SK Life Science LabsTargeted Protein Degradation
Revolutionizing Cancer Therapy: Insights from SK Life Science Labs Dr. Mohammad on p300 and SMARCA2 Targeted Protein Degradation Technologies
2024-03-07
Funding PhotoimmunotherapySeries E FundingRakuten Medical
Rakuten Medical Completes $119 Million Series E Financing to Develop Alluminox™ Platform
2024-03-06
PRNEWSWIRE AntengeneAACRImmunology
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms
2024-03-06
PRNEWSWIRE Hummingbird BioscienceAnti-HER3 AntibodyAnti-VISTA AntibodyAACR
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024
2024-03-06
Manufacturing Novo NordiskJohnson & JohnsonAmgenBristol Myers SquibbAstraZenecaMerck KGaAModernaDaiichi Sankyo
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
Interviews HPV Vaccine
An Interview with the Inventor of HPV Vaccine, Ian Frazer, Building a Firewall for Public Health
2024-02-29
Partnerships Novo NordiskTargeted Protein Degradation
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Partner Brain TumorBIAL Award in Biomedicineglioblastomas Partner
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Trials & Approvals DACDegrader-Antibody ConjugatePROTACADCAntibody-Drug ConjugateBTK DegraderAntibody Neodegrader Conjugate
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
R&D DACDegrader-Antibody ConjugatePROTAC
Degrader-Antibody Conjugates (DACs): Targeted Protein Degradation for Therapeutics
2024-02-19
Trials & Approvals NASHMASH
Resmetirom Offers Hope for MASH Patients: Positive Phase 3 Results for Liver Fibrosis
2024-02-15
1 2 3 4 5 … 95
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top